对心脏周围疾病的手术方法:有什么新鲜事?
David Moros1, Anthony Zaki2, Michael Zhen-Yu Tong2
1Department of Thoracic and Cardiovascular Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. morosd@ccf.org.
Current cardiology reports
|November 8, 2023
概括
使用心肺绕道 (CPB) 进行激进心周切除术可以改善结局和存活率,而不会增加风险. 这种方法促进了更完整的切除,减少了复发和重新干预的需要,以改善患者的生存率.
科学领域:
- 心血管外科心血管外科
- 胸部外科手术 胸部外科手术
背景情况:
- 心切除术是收缩性心周炎的关键手术.
- 不断发展的外科手术技术旨在改善结果并减少复发.
研究的目的:
- 审查心周切除术技术的进展.
- 专注于心肺绕道 (CPB) 和急性心周切除的作用.
主要方法:
- 综述最近关于心周切除术的研究和文献.
- 对CPB对程序风险和结果的影响分析.
- 评估心周切除的程度.
主要成果:
- 心肺绕道 (CPB) 不会增加手术风险,也不会对存活率产生负面影响.
- CPB促进了更激进的心周切除.
- 带有CPB的急性心膜切除术与术后结果的改善,复发率的减少和更好的生存率有关.
结论:
- 极端心膜切除术,特别是当由CPB促进时,对于成功治疗至关重要.
- CPB增强了实现完全切除的能力,最大限度地减少了收缩性心膜炎的复发.
- 改善的术后结果和生存率与使用CPB的激进切除策略有关.
相关概念视频
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Pericarditis I: Introduction
10
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
10
Pericarditis II: Clinical Features and Diagnostic Tests
9
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
9


